U.S. markets close in 4 hours 48 minutes

Cencora, Inc. (COR)

NYSE - Nasdaq Precio en tiempo real. Divisa en USD.
Añadir a la lista de seguimiento
226.29-2.91 (-1.27%)
A partir del 11:12AM EDT. Mercado abierto.

Cencora, Inc.

1 West First Avenue
Conshohocken, PA 19428-1800
United States
610 727 7000
https://www.cencora.com

Sector(es)Healthcare
IndustriaMedical Distribution
Empleados a tiempo completo46,000

Ejecutivos clave

NombreTítuloPagarEjecutadoAño de nacimiento
Mr. Steven H. CollisChairman, President & CEO5.01M13.79M1961
Mr. James F. Cleary Jr.Executive VP & CFO1.95M3.8M1963
Dr. Robert P. Mauch Ph.D., PharmDExecutive VP & COO2.7MN/D1967
Ms. Gina K. ClarkExecutive VP and Chief Communications & Administration Officer1.57M5.01M1957
Ms. Elizabeth S. CampbellExecutive VP & Chief Legal Officer1.63M318.67k1975
Mr. Lazarus KrikorianSenior VP, Chief Accounting Officer & Corporate ControllerN/DN/D1965
Bennett S. MurphySenior Vice President of Investor RelationsN/DN/DN/D
Ms. Jennifer E. DubasSenior VP & Chief Compliance OfficerN/DN/DN/D
Ms. Silvana BattagliaExecutive VP & Chief Human Resources Officer1.58MN/D1968
Ms. Leslie E. DonatoExecutive VP & Chief Strategy OfficerN/DN/D1970
Los importes son a partir de 31 de diciembre de 2023 y los valores de compensación son para el último año fiscal que finaliza en esa fecha. Pago corresponde al salario, las bonificaciones, etc. Ejecutado corresponde al valor de las opciones ejecutadas durante el año fiscal. Divisa en USD.

Descripción

Cencora, Inc. sources and distributes pharmaceutical products. The company's U.S. Healthcare Solutions segment distributes pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to acute care hospitals and health systems, independent and chain retail pharmacies, mail order pharmacies, medical clinics, long-term care and alternate site pharmacies, and other customers; provides pharmacy management, staffing, and other consulting services; supply management software to retail and institutional healthcare providers; packaging solutions to various institutional and retail healthcare providers; clinical trial support, product post-approval, and commercialization support services; data analytics, outcomes research, and additional services for biotechnology and pharmaceutical manufacturers; pharmaceuticals, vaccines, parasiticides, diagnostics, micro feed ingredients, and other products to the companion animal and production animal markets; and sales force services to manufacturers. This segment also distributes plasma and other blood products, injectable pharmaceuticals, vaccines, and other specialty products; and provides other services to physicians who specialize in various disease states, such as oncology, as well as to other healthcare providers, including hospitals and dialysis clinics. Its International Healthcare Solutions segment offers international pharmaceutical wholesale and related service, and global commercialization services; distributes pharmaceuticals, other healthcare products, and related services to pharmacies, doctors, health centers, and hospitals primarily in Europe; and provides specialty transportation and logistics services for the biopharmaceutical industry. The company was formerly known as AmerisourceBergen Corporation and changed its name to Cencora, Inc. in August 2023. Cencora, Inc. was incorporated in 2001 and is headquartered in Conshohocken, Pennsylvania.

Gestión corporativa

La calificación ISS Governance QuickScore de Cencora, Inc. a partir del 29 de abril de 2024 es 3. Las puntuaciones principales son Auditoría: 2; Junta: 3; Derechos del accionista: 6; Compensación: 7.

Las puntuaciones de la gestión corporativa son cortesía de Servicios de accionistas institucionales (ISS). Las puntuaciones indican una posición decil en relación con el índice o la región. Una puntuación decil 1 indica que el riesgo de gestión es menor, mientras que una puntuación decil 10 indica que el riesgo de gestión es mayor.